Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02499887 · ClinicalTrials.gov registry record · NA
Repeat Emergency Department Visits Among Patients With Asthma and COPD
A NA study, sponsored by State University of New York at Buffalo.
- Terminated
- Registry status
- NA
- Development phase
- 6
- Enrollment target
NCT02499887: Clinical Trial NA study, sponsored by State University of New York at Buffalo.
NCT02499887 is a NA study that was terminated before completion, run by State University of New York at Buffalo. The registered enrollment target is 6 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02499887, a NA study, was terminated before completion, sponsored by State University of New York at Buffalo.
- TERMINATED
- Registry status
- NA
- Development phase
- 6 participants
- Enrollment target
Study Summary
The purpose of the proposed study is to determine whether the addition of inhaled corticosteroids to treatment with oral corticosteroids and albuterol would reduce repeat emergency department (ED) visits among patients treated for acute exacerbations of asthma and COPD discharged from the emergency department to home. The investigators hypothesize that patients treated with inhaled corticosteroids in addition to oral corticosteroids and albuterol will have lower rates of 30-day return visits to the emergency department than those patients treated with oral corticosteroids and albuterol only.
Primary Outcome
Subjects' medical records will be reviewed for the 30 day period following ED discharge to determine if they return to the treating ED or another regional ED for treatment of an acute asthma/COPD exacerbation. Regional ED records will be queried by use of data maintained by HEALTHeLINK, our regional health information organization system. This will allow for more complete capture of ED return visits that could be obtained by looking only at a single ED.
Interventions
- DRUG Prednisone
- DRUG albuterol
- DRUG beclamethasone dipropionate
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6 participants |
| Start Date | 2016-01 |
| Est. Completion | 2016-09 |
| Phase | NA |
Why NCT02499887 stopped before completion
NCT02499887 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 6 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 3 interventions - of which Prednisone is the first listed.
NCT02499887 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02499887 about?
NCT02499887 is a clinical study titled "Repeat Emergency Department Visits Among Patients With Asthma and COPD". The purpose of the proposed study is to determine whether the addition of inhaled corticosteroids to treatment with oral corticosteroids and albuterol would reduce repeat emergency department (ED) visits among patients treated for acute exacerbations of asthma and COPD discharged from the emergency ...
What is the current status of trial NCT02499887?
This trial is currently terminated. It is a NA study. The enrollment target is 6 participants. The study started on 2016-01. Estimated completion is 2016-09.
What interventions are being tested in trial NCT02499887?
The interventions under investigation include: Prednisone (DRUG), albuterol (DRUG), beclamethasone dipropionate (DRUG).
Who is sponsoring clinical trial NCT02499887?
This trial is sponsored by State University of New York at Buffalo, which has 243 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02499887's enrollment target sits among peer trials
6 1983rd of 2000 higher than 13 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia